Pacira BioSciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	716.79	700.97	674.98	666.82	541.53	429.65
Revenue Growth (YoY)	3.14%	3.85%	1.22%	23.14%	26.04%	2.05%
Cost of Revenue	246.14	252.01	260.93	284.09	195.8	176.75
Gross Profit	470.65	448.96	414.05	382.73	345.73	252.9
Selling, General & Admin	346.77	294.1	269.44	254.52	199.35	193.52
Amortization of Goodwill & Intangibles	57.29	57.29	57.29	57.29	13.55	7.87
Other Operating Expenses	-	-	-	-	42.91	-
Operating Expenses	405.51	351.39	326.73	311.8	255.81	201.38
Operating Income	65.15	97.57	87.32	70.93	89.92	51.52
Interest Expense	-18.23	-16.57	-20.31	-39.98	-31.75	-25.67
Interest & Investment Income	25.99	19.69	11.44	4.54	0.9	4.63
Other Non Operating Income (Expenses)	-10.73	-0.37	-0.19	-1.29	-0.07	1.23
EBT Excluding Unusual Items	62.18	100.32	78.28	34.21	59	31.71
Merger & Restructuring Charges	-13.03	-9.99	-3.07	-11.25	-	0.04
Impairment of Goodwill	-	-163.24	-	-	-	-
Gain (Loss) on Sale of Investments	4.23	-	-	-10	-2.6	1.62
Asset Writedown	-25.87	-	-	-26.13	-	-
Legal Settlements	16.15	-	-	-	-	-
Other Unusual Items	-1.83	9.81	-13.5	26.48	-	-13.28
Pretax Income	41.83	-63.11	61.7	13.3	56.4	20.09
Income Tax Expense	20.39	36.45	19.75	-2.61	14.42	-125.43
Net Income	21.44	-99.56	41.96	15.91	41.98	145.52
Net Income to Common	21.44	-99.56	41.96	15.91	41.98	145.52
Net Income Growth	-	-	163.72%	-62.10%	-71.15%	-
Shares Outstanding (Basic)	45	46	46	46	44	43
Shares Outstanding (Diluted)	46	46	52	47	46	44
Shares Change (YoY)	-1.02%	-11.03%	11.69%	1.99%	4.46%	5.22%
EPS (Basic)	0.47	-2.15	0.91	0.35	0.95	3.41
EPS (Diluted)	0.47	-2.15	0.89	0.34	0.92	3.33
EPS Growth	-	-	160.68%	-63.04%	-72.37%	-
Free Cash Flow	124.2	178.75	139.49	115.2	79.85	39.23
Free Cash Flow Per Share	2.71	3.87	2.68	2.48	1.75	0.90
Gross Margin	65.66%	64.05%	61.34%	57.40%	63.84%	58.86%
Operating Margin	9.09%	13.92%	12.94%	10.64%	16.61%	11.99%
Profit Margin	2.99%	-14.20%	6.22%	2.39%	7.75%	33.87%
Free Cash Flow Margin	17.33%	25.50%	20.67%	17.28%	14.74%	9.13%
EBITDA	150.57	176.36	162.9	151.93	118.47	71.42
EBITDA Margin	21.01%	25.16%	24.13%	22.78%	21.88%	16.62%
D&A For EBITDA	85.42	78.79	75.57	81	28.55	19.91
EBIT	65.15	97.57	87.32	70.93	89.92	51.52
EBIT Margin	9.09%	13.92%	12.94%	10.64%	16.61%	11.99%
Effective Tax Rate	48.75%	-	32.00%	-	25.57%	-
Revenue as Reported	716.79	700.97	674.98	666.82	541.53	429.65

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q